The anti-tumor activity of HSP-90 therapeutic cancer vaccine (AST-021p) combine with TLR2/3 agonist in a MMTV-neu transgenic model

AST-021p - Aston Sci.

https://jitc.bmj.com//content/9/Suppl_2/A901

Jinho Kang 1; Eunkyo Joung 2; Hunwoo Shin 3; Byung cheol Ahn 4; Eunjung Jung 4; Hun Jung 3; Kyong Hwa Park 1

Oct 1, 2021